Reshma Rangwala
Chief Tech/Sci/R&D Officer bij KARYOPHARM THERAPEUTICS INC.
Vermogen: 517 826 $ op 31-03-2024
Actieve functies van Reshma Rangwala
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-04-2022 | - |
Loopbaan van Reshma Rangwala
Eerdere bekende functies van Reshma Rangwala
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 15-09-2020 | 28-03-2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01-05-2017 | 01-07-2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01-06-2012 | 01-05-2017 |
Opleiding van Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Beurs
- Insiders
- Reshma Rangwala
- Ervaring
